1 active not recruiting, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
Follow (225)Ac-PSMA-617: new trials by email Literature Review of (225)Ac-PSMA-617 trials Research Report on (225)Ac-PSMA-617
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 177 Lutetium Prostate-Specific Membrane Antigen 617, Actinium-225 Prostate-Specific Membrane Antigen 617, Non-investigational, Prostatectomy - Prostate Cancer, Prostate Cancer (Diagnosis) | Phase 1 | Recruiting | Thomas Hope | 45 | 2025-07-08 | 2026-08-28 |
| Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer 225^Ac-PSMA-617, 68^Ga-PSMA-11 - Prostatic Neoplasms, Castration-Resistant | Phase 1 | Active not recruiting | Endocyte | 101 | 2021-04-01 | 2026-04-30 |
Prostatic Neoplasms (2) · Disease (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Prostatic Neoplasms, Castration-Resistant (1) · Urogenital Neoplasms (1)
Endocyte (1) · Thomas Hope (1)
Australia (1) · South Africa (1) · United States (1)